{"gene":"CERT1","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":2004,"finding":"CERT catalyzes intermembrane transfer of ceramide via its START domain, with strict stereo-specificity for the natural D-erythro isomer and an acyl-chain length limit (efficient for C14–C20 but not longer chains); it does not transfer sphingosine or sphingomyelin; (1R,3R)-HPA-12 was identified as an antagonist of the CERT START domain in vitro.","method":"Cell-free lipid transfer assay, lipid binding assay, radiolabeled ceramide analogs","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with multiple lipid species, stereospecificity demonstrated, replicated across multiple conditions in one rigorous study","pmids":["15596449"],"is_preprint":false},{"year":2006,"finding":"CERT requires both its PH domain (for Golgi targeting via PI4P) and its FFAT motif (for interaction with ER-resident VAP-A and VAP-B) for efficient ER-to-Golgi ceramide transport in cells; VAP-A and VAP-B co-immunoprecipitate with CERT and this interaction is abolished by FFAT motif mutations; neither FFAT nor PH domain mutations affect ceramide transfer activity in cell-free assays, indicating these domains spatially restrict the random transfer activity of the START domain.","method":"Co-immunoprecipitation, FFAT motif mutagenesis, semi-intact cell ceramide transport assay, cell-free lipid transfer assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (Co-IP, mutagenesis, cell-free and cell-based transport assays), single rigorous study with comprehensive controls","pmids":["16895911"],"is_preprint":false},{"year":2007,"finding":"CERT activity is down-regulated by multiple phosphorylations at a serine-repeat motif (SRM), a substrate for casein kinase I; phosphorylation induces an autoinhibitory intramolecular interaction between the PH and START domains, inactivating both PI4P binding and ceramide transfer activities; loss of sphingomyelin and cholesterol causes dephosphorylation of CERT to activate it.","method":"In vitro phosphorylation assays, domain interaction assays, PI4P-binding assay, ceramide transfer assay, cell-based sphingomyelin depletion experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal biochemical assays plus cellular readouts in one study, with defined mechanistic outcome","pmids":["17442665"],"is_preprint":false},{"year":2008,"finding":"Crystal structures of the CERT START domain in apo-form and in complex with ceramides of different acyl chain lengths reveal that one ceramide molecule is buried in a long amphiphilic cavity; hydrogen-bond networks at the far end of the cavity mediate stereo-specific ceramide recognition; cavity size dictates the acyl-chain length limit; the alpha-3 helix and Omega1 loop are proposed to act as a gate for ceramide entry.","method":"X-ray crystallography (crystal structures of apo and ceramide-bound START domain)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structures with functional validation of chain-length specificity, replicated across multiple ceramide species","pmids":["18184806"],"is_preprint":false},{"year":2007,"finding":"CERT is preferentially distributed to the Golgi region in cells; its PH domain specifically recognizes phosphatidylinositol 4-monophosphate (PI4P) at the Golgi for targeting; membrane contact sites between ER and Golgi are proposed as sites of efficient ceramide transfer.","method":"Subcellular fractionation, domain binding studies, fluorescence localization","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — localization and domain-binding data from review consolidating prior experimental work, but this paper is a review summarizing established findings","pmids":["17314061"],"is_preprint":false},{"year":2007,"finding":"PP2Cepsilon, an ER-resident transmembrane phosphatase, dephosphorylates CERT in a VAPA-dependent manner; PP2Cepsilon expression causes redistribution of CERT from cytoplasm to Golgi and enhances CERT-VAPA association; PP2Cepsilon knockdown attenuates CERT-VAPA interaction and sphingomyelin synthesis, identifying CERT as a physiological substrate of PP2Cepsilon.","method":"Yeast two-hybrid, co-immunoprecipitation, siRNA knockdown, subcellular localization by immunofluorescence, sphingomyelin synthesis assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal interaction mapping, gain- and loss-of-function with two orthogonal readouts (CERT phosphorylation state and SM synthesis)","pmids":["18165232"],"is_preprint":false},{"year":2009,"finding":"Crystal structures of the CERT START domain bound to HPA inhibitors reveal that the Omega1 loop adopts a different conformation compared to ceramide-bound structures, with Trp473 moving inside the cavity; surface plasmon resonance confirmed that Trp473 is important for membrane interaction, suggesting a gating mechanism for ceramide loading/unloading.","method":"X-ray crystallography, surface plasmon resonance","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures plus SPR validation of key residue, single lab but two orthogonal methods","pmids":["20036255"],"is_preprint":false},{"year":2011,"finding":"Chlamydia trachomatis effector protein IncD directly binds the PH domain of CERT and recruits CERT to the inclusion membrane; this redirects ceramide trafficking toward the inclusion; CERT and VAP-A/B co-localize at ER-inclusion membrane contact sites; depletion of CERT or VAP proteins impairs bacterial development.","method":"Co-immunoprecipitation, ectopic expression, siRNA knockdown, immunofluorescence co-localization, bacterial development assay","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding demonstrated, loss-of-function phenotype, replicated across two independent laboratories (PMID 21731489 and 21909260)","pmids":["21731489","21909260"],"is_preprint":false},{"year":2012,"finding":"The CERT PH domain structure determined by solution NMR reveals a characteristic basic groove near the canonical PI4P recognition site; this basic groove coordinates efficient PI4P recognition and Golgi targeting; mutations of basic groove residues cause Golgi mislocalization in living cells.","method":"Solution NMR structure determination, NMR chemical shift perturbation binding assay, cell-based localization with mutants","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with functional mutagenesis and cellular validation, single lab with multiple orthogonal methods","pmids":["22869376"],"is_preprint":false},{"year":2014,"finding":"Phosphorylation of CERT at serine 315, adjacent to the FFAT motif, markedly enhances CERT-VAP interaction and ER-to-Golgi ceramide transport activity; the phosphomimetic S315E mutant shows higher ceramide transport activity in a semi-intact cell system; S315 phosphorylation increases under sphingolipid depletion conditions and acts additively with SRM dephosphorylation to activate CERT.","method":"Semi-intact cell ceramide transport assay, co-immunoprecipitation, CERT mutant analysis, immunofluorescence, biochemical phosphorylation analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical reconstitution in semi-intact cells, multiple mutant constructs, and cellular imaging, all in one study","pmids":["24569996"],"is_preprint":false},{"year":2014,"finding":"Both the N- and C-terminal cytoplasmic regions of Chlamydia IncD are required for binding to the CERT PH domain; the IncD transmembrane region forms SDS-resistant homodimers and higher-order oligomers, which may facilitate high-affinity CERT binding.","method":"Co-transfection and co-immunoprecipitation, native gel electrophoresis, phylogenetic analysis","journal":"Infection and immunity / Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — direct binding defined by mutagenesis and co-IP, single lab with two orthogonal methods (Co-IP and native gel)","pmids":["24595143","30314703"],"is_preprint":false},{"year":2018,"finding":"Hyperphosphorylation-mimetic SRM substitutions (10E variant) cause an intramolecular interaction between the SRM and positively charged regions of the PH domain, directly competing with PI4P binding; this reduces PI4P-embedded membrane binding in cell-free assays and Golgi targeting in living cells.","method":"Solution NMR, PI4P-binding assay, fluorescence Golgi targeting assay in cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — NMR plus cell-free binding assay plus cellular imaging, single lab with three orthogonal methods","pmids":["29848549"],"is_preprint":false},{"year":2016,"finding":"Targeting ceramide transport from ER to mitochondria using a mitoCERT construct (CERT with an outer mitochondrial membrane anchor) induces Bax-dependent apoptosis; apoptosis requires the ceramide transfer domain, VAP interaction via the ER, de novo ceramide synthesis, and is abolished by a bacterial ceramidase targeted to mitochondria — demonstrating that ER ceramide translocation to mitochondria directly commits cells to apoptosis.","method":"Engineered mitoCERT construct, domain deletion and FFAT mutants, CERT inhibitor HPA-12, de novo ceramide synthesis inhibition, mitochondria-targeted ceramidase, cell death assays","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal loss-of-function approaches (domain deletions, chemical inhibitors, enzymatic degradation) all converging on the same mechanistic conclusion in one rigorous study","pmids":["27888218"],"is_preprint":false},{"year":2008,"finding":"UVB irradiation induces formation of a stable CERT homotrimer complex in keratinocytes and other cell lines; the homotrimer formation requires the middle region domain of CERT (not the PH or START domains); CERT in the homotrimer has decreased ceramide binding activity; homotrimer formation correlates with decreased sphingomyelin synthesis and increased apoptosis.","method":"Western immunoblot, mass spectrometry, ceramide binding assay, siRNA knockdown, CERT inhibitor HPA-12","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (MS, WB, binding assay), domain mapping, but single lab","pmids":["18411267"],"is_preprint":false},{"year":2019,"finding":"CERT function is down-regulated by multisite SRM phosphorylation primed by protein kinase D (activated by diacylglycerol produced during ceramide-to-sphingomyelin conversion), creating a feedback mechanism; S315 phosphorylation enhances CERT-VAP binding; the PI4P pool at trans-Golgi (regulated by PI4-kinases and OSBP) controls CERT-dependent ceramide transport.","method":"Biochemical phosphorylation analysis, cell-based assays, lipid measurement (review of experimental findings)","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — review paper consolidating experimental findings from multiple studies; PKD-primed SRM phosphorylation established in prior experimental work cited within","pmids":["31254361"],"is_preprint":false},{"year":2018,"finding":"CERT (STARD11) mediates palmitate-stimulated extracellular vesicle/exosome biogenesis in liver cells; STARD11-deficient cells release fewer extracellular vesicles, exhibit intracellular ceramide accumulation, and show reduced cellular viability; STARD11 co-localizes with ER and multivesicular bodies.","method":"STARD11 knockout cell lines, extracellular vesicle quantification, ceramide measurement, immunofluorescence co-localization","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout with multiple readouts (EV number, ceramide levels, cell viability), single lab","pmids":["30139741"],"is_preprint":false},{"year":2020,"finding":"De novo missense variants in CERT1 causing intellectual disability include gain-of-function mutations (e.g., S135P) that impair SRM hyperphosphorylation and thus prevent down-regulation of CERT activity; these mutations cause abnormal CERT activation and punctate subcellular redistribution.","method":"Whole exome sequencing, biochemical analysis of SRM phosphorylation, subcellular localization imaging","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical validation of phosphorylation defect plus cellular localization, single lab","pmids":["33347465"],"is_preprint":false},{"year":2021,"finding":"ID-associated CERT1 mutations S132L and G243R impair SRM hyperphosphorylation, rendering the proteins excessively active and causing punctate subcellular redistribution; a frameshift variant (dupAA) that does not impair SRM phosphorylation does not cause aberrant activity or localization, serving as a disease-matched negative control.","method":"Biochemical phosphorylation analysis, subcellular localization imaging, patient variant characterization","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical and cellular analyses with negative control variant, single lab","pmids":["34688657"],"is_preprint":false},{"year":2022,"finding":"A previously uncharacterized cluster of lysine/arginine residues on the outer surface of a coiled-coil region of CERT is involved in SRM phosphorylation-dependent repression of CERT function; alanine substitutions in this cluster release repression of SM synthesis, PI4P-binding, VAP binding, ceramide transfer, and Golgi localization, and partially destabilize the CERT trimer.","method":"Site-directed mutagenesis, SM synthesis assay, PI4P-binding assay, VAP co-IP, ceramide transfer assay, subcellular localization","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays with alanine-scanning mutagenesis, single lab","pmids":["35955719"],"is_preprint":false},{"year":2022,"finding":"Hyperosmotic stress induces S315 phosphorylation of CERT without altering SRM phosphorylation; under these conditions, CERT-VAP-A binding is enhanced throughout the ER (not only at ER-Golgi MCS), demonstrating that S315 phosphorylation and SRM dephosphorylation can be uncoupled and that they have distinct spatial consequences.","method":"Biochemical phosphorylation analysis, co-immunoprecipitation, immunofluorescence subcellular localization","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP and localization under defined stress conditions, single lab with two orthogonal methods","pmids":["35409383"],"is_preprint":false},{"year":2022,"finding":"HSV-1 pUL21, a viral phosphatase adaptor, directly interacts with CERT with submicromolar affinity; pUL21 promotes dephosphorylation of CERT, activating it and accelerating ceramide-to-sphingomyelin conversion; solution structure of the pUL21 C-terminal domain in complex with CERT PH and START domains was determined by SAXS; a single conserved pUL21 surface residue disrupts CERT binding in vitro and in cells.","method":"Click chemistry sphingolipid profiling, surface plasmon resonance, small-angle X-ray scattering (SAXS), site-directed mutagenesis, co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — solution structure, affinity measurement, mutagenesis, and functional lipid profiling in one rigorous study","pmids":["36243114"],"is_preprint":false},{"year":2023,"finding":"Several CERT1 intellectual disability variants fall in a previously uncharacterized dimeric helical domain that enables CERT homeostatic autoregulation/inactivation; disruption of this domain by de novo missense variants causes unchecked sphingolipid production; pharmacological CERT inhibition corrects morphological and motor abnormalities in a Drosophila model.","method":"Structural characterization of dimeric helical domain, patient variant analysis, Drosophila model with pharmacological rescue","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — structural domain characterization, multiple variants, and in vivo pharmacological rescue, replicated across 31 patients","pmids":["36976648"],"is_preprint":false},{"year":2022,"finding":"VAP-A and its binding partner CERT localize to multivesicular bodies (MVBs); knockdown of CERT or VAP-A reduces RNA content of small extracellular vesicles and ceramide in EVs; ceramide generated via the VAP-A/CERT axis at ER-MVB membrane contact sites drives biogenesis of a select RNA-containing EV population.","method":"siRNA knockdown, EV isolation and RNA/lipid profiling, live imaging, colocalization experiments","journal":"Developmental cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockdown with multiple readouts (EV RNA, ceramide, MVB morphology), single lab","pmids":["35421371"],"is_preprint":false},{"year":2023,"finding":"CERT preferentially utilizes PI4P generated by PI4KB recruited to the Golgi by C10orf76 (rather than ACBD3) for ceramide transport; super-resolution microscopy shows C10orf76 localizes predominantly at distal Golgi where sphingomyelin synthesis primarily occurs, while ACBD3 is at more proximal regions — establishing a C10orf76-PI4KB axis that orchestrates CERT-mediated ceramide delivery to distal Golgi.","method":"Genome-wide screening, PI4P measurement, super-resolution microscopy, knockdown/knockout of PI4KB, ACBD3, C10orf76","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide screen followed by super-resolution imaging and functional knockdown, single lab but multiple orthogonal approaches","pmids":["37195633"],"is_preprint":false},{"year":2023,"finding":"CERT mediates intermembrane transfer of alkylacylglycerol (AAG) in vitro; CERT inhibition (HPA-12) or START domain deletion abolishes AAG transfer; CERT suppression in HEK293 cells increases plasmanyl-PC levels (an AAG metabolite), and CERT re-introduction reduces these levels — identifying CERT as a transporter of AAG from ER to Golgi for ether phospholipid biosynthesis.","method":"In vitro lipid transfer assay, HPA-12 inhibition, domain deletion, CERT knockdown/rescue, cellular lipid measurement","journal":"Archives of biochemistry and biophysics","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro transfer assay plus cellular gain/loss-of-function, single lab","pmids":["38110110"],"is_preprint":false},{"year":2024,"finding":"Molecular dynamics simulations propose a membrane-assisted mechanism for ceramide release from the CERT START domain, in which membrane contact acts as allosteric effector and a single phosphatidylcholine lipid intercalates into the START cavity to facilitate ceramide egress; free energy calculations and experimental lipidomics confirmed CERT forms stable complexes with phosphatidylcholine in addition to ceramide.","method":"Molecular dynamics simulations, free energy calculations, experimental lipidomics","journal":"The journal of physical chemistry B","confidence":"Low","confidence_rationale":"Tier 4 / Weak — primarily computational with limited experimental lipidomics validation; mechanism not directly demonstrated by biochemical reconstitution","pmids":["38903016"],"is_preprint":false},{"year":2010,"finding":"Human biliverdin reductase (hBVR) binds to GPBP (CERT1 long isoform) and down-regulates its TNF-alpha-stimulated kinase activity in HEK293A cells; hBVR siRNA knockdown modulates TNF-alpha/NF-κB-stimulated GPBP expression; the interacting domain was mapped to the C-terminal CX10C motif of hBVR.","method":"Co-immunoprecipitation, siRNA knockdown, kinase activity assay, peptide mapping","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP with domain mapping and functional kinase assay, single lab","pmids":["20177069"],"is_preprint":false},{"year":2011,"finding":"GPBP-1 (the long isoform of CERT1) accumulates in cytoplasm of differentiating myoblasts prior to myosin synthesis; GPBP-1-deficient myoblasts show defective myofibril formation; GPBP-1 targets GIP130 (a 130-kDa interacting protein), which binds myosin and promotes its myofibrillar assembly.","method":"Loss-of-function (deficiency), overexpression, co-immunoprecipitation (GPBP-GIP130), myofibril formation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP identifying binding partner plus cellular loss-of-function phenotype, single lab","pmids":["21832087"],"is_preprint":false},{"year":2021,"finding":"CERTL (long isoform) binds to amyloid precursor protein (APP) as shown by co-immunoprecipitation; recombinant CERTL modifies Aβ aggregation and reduces Aβ neurotoxicity in neuroblastoma cells; CERTL overexpression in 5xFAD mouse brains reduces ceramide d18:1/16:0 levels, increases sphingomyelin, decreases Aβ formation, and modulates microglia toward a less pro-inflammatory phenotype.","method":"Co-immunoprecipitation, immunofluorescence, AAV-mediated overexpression in mice, mass spectrometry lipidomics, immunohistochemistry, behavior tests","journal":"Alzheimer's research & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus in vivo mouse overexpression with lipidomic and immunological readouts, single lab with multiple orthogonal methods","pmids":["33597019"],"is_preprint":false},{"year":2018,"finding":"CERT protein expression is reduced in insulin-resistance models via caspase-dependent cleavage; inhibiting CERT activity potentiates lipotoxicity-induced insulin signaling defects; CERT overexpression in vitro and in vivo decreases muscle ceramide content and improves insulin signaling; inhibition of caspase activity prevents ceramide-induced insulin signaling defects.","method":"CERT knockdown/overexpression in muscle cells, in vivo overexpression, insulin signaling assays, ceramide measurement, caspase inhibition","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with defined biochemical readouts (ceramide levels, insulin signaling), single lab with multiple approaches","pmids":["29759974"],"is_preprint":false},{"year":2017,"finding":"C. psittaci recruits CERT to its inclusion; CERT knockout (CRISPR/Cas9) impairs C. psittaci infection, affecting inclusion growth and infectious progeny formation; CERT-independent sphingolipid uptake pathways exist in CERT-KO cells, and HPA-12 sensitive factors beyond CERT are involved in sphingolipid trafficking to C. psittaci.","method":"CRISPR/Cas9 CERT knockout, CERT chemical inhibition (HPA-12), fluorescent sphingolipid uptake assay, bacterial development quantification","journal":"Cellular microbiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with multiple functional readouts, single lab","pmids":["28544656"],"is_preprint":false},{"year":2025,"finding":"In Drosophila, loss of dcert leads to elevated short-chain ceramide and reduced phosphatidylethanolamine ceramide; dcert mutants show reduced photoreceptor electrical responses to light and impaired PIP2 resynthesis following PLC activation; reducing ceramide synthesis at the ER suppresses the dcert light response phenotype — establishing that CERT-mediated ceramide transfer from ER to Golgi regulates G-protein coupled phospholipase C signaling in vivo.","method":"Loss-of-function alleles, electrophysiology (ERG), lipidomics, genetic suppressor (ceramide synthesis reduction), rescue with wild-type gene","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with physiological and lipidomic readouts in Drosophila, preprint not yet peer-reviewed","pmids":[],"is_preprint":true}],"current_model":"CERT1/CERT is a cytosolic ceramide transfer protein that extracts ceramide from the ER via its START domain (which binds one ceramide molecule stereospecifically in a hydrophobic cavity) and delivers it to the trans-Golgi for sphingomyelin synthesis; ER targeting is mediated by a FFAT motif that binds VAP-A/B, Golgi targeting by a PH domain that recognizes PI4P generated specifically by the C10orf76-PI4KB axis at distal Golgi; CERT activity is regulated by a phosphorylation-feedback loop in which PKD-primed multisite SRM phosphorylation causes autoinhibitory PH-START domain interaction (releasing Golgi binding) while phosphorylation at S315 enhances VAP binding and activates CERT, and PP2Cepsilon dephosphorylates CERT at the ER to reactivate it; de novo ID-associated gain-of-function mutations impair SRM phosphorylation-dependent autoregulation, including via a newly identified dimeric helical domain, causing uncontrolled sphingolipid production; CERT also transfers alkylacylglycerol for ether phospholipid biosynthesis, participates in ceramide delivery to multivesicular bodies for RNA-containing EV biogenesis, and is co-opted by intracellular pathogens (Chlamydia, HSV-1) via direct protein-protein interactions with CERT's PH or START domains."},"narrative":{"mechanistic_narrative":"CERT1 (CERT/STARD11/GPBP) is a cytosolic lipid-transfer protein that drives non-vesicular delivery of ceramide from the endoplasmic reticulum to the Golgi for sphingomyelin synthesis [PMID:15596449, PMID:16895911]. Its START domain extracts and stereospecifically binds a single D-erythro ceramide within an amphiphilic cavity whose size sets an acyl-chain-length limit, with the Omega1 loop and Trp473 acting as a gate for lipid loading and release [PMID:15596449, PMID:18184806, PMID:20036255]. Spatial coupling of this intrinsically random transfer activity is achieved by two targeting modules: a FFAT motif that binds the ER-resident proteins VAP-A/VAP-B and a PH domain that recognizes Golgi PI4P through a basic groove, positioning CERT at ER–Golgi membrane contact sites [PMID:16895911, PMID:22869376]; CERT preferentially consumes the distal-Golgi PI4P pool generated by a C10orf76–PI4KB axis where sphingomyelin synthesis occurs [PMID:37195633]. CERT activity is governed by a phosphorylation feedback loop: multisite serine-repeat-motif (SRM) phosphorylation, primed by diacylglycerol-activated PKD, drives an autoinhibitory intramolecular SRM–PH interaction that competes with PI4P binding and silences transfer, while the ER phosphatase PP2Cepsilon reactivates CERT in a VAP-dependent manner, and phosphorylation at S315 adjacent to the FFAT motif independently enhances VAP binding to activate the protein [PMID:17442665, PMID:18165232, PMID:24569996, PMID:29848549, PMID:35409383]. Beyond canonical sphingomyelin production, CERT supplies ceramide for multivesicular-body/extracellular-vesicle biogenesis at ER–MVB contact sites and transfers alkylacylglycerol for ether phospholipid synthesis [PMID:35421371, PMID:38110110], and targeted ER-to-mitochondria ceramide transport commits cells to Bax-dependent apoptosis [PMID:27888218]. De novo gain-of-function CERT1 missense variants causing intellectual disability cluster in regulatory regions—including the SRM and a dimeric helical domain—where they impair SRM hyperphosphorylation-dependent autoinhibition, producing unchecked sphingolipid production that is corrected by pharmacological CERT inhibition in a Drosophila model [PMID:33347465, PMID:34688657, PMID:36976648]. CERT is also co-opted by intracellular pathogens, with Chlamydia IncD and HSV-1 pUL21 binding CERT domains directly to redirect or activate ceramide trafficking [PMID:21731489, PMID:21909260, PMID:36243114].","teleology":[{"year":2004,"claim":"Established that CERT is a bona fide ceramide carrier, defining its core biochemical activity and substrate selectivity.","evidence":"Cell-free lipid transfer and binding assays with radiolabeled ceramide analogs","pmids":["15596449"],"confidence":"High","gaps":["Did not resolve how the random transfer activity is spatially organized in cells","Structural basis of stereospecificity not yet defined"]},{"year":2006,"claim":"Resolved how CERT's intrinsically directionless transfer is harnessed for vectorial ER-to-Golgi transport, showing the FFAT (VAP) and PH (PI4P) modules spatially constrain the START domain.","evidence":"Co-IP with VAP-A/B, FFAT mutagenesis, semi-intact cell transport and cell-free transfer assays","pmids":["16895911"],"confidence":"High","gaps":["Did not address how the two targeting events are coordinated dynamically","Regulation of the cycle unknown"]},{"year":2007,"claim":"Defined the principal off-switch—SRM phosphorylation causing autoinhibitory PH–START interaction—and linked it to sphingolipid-sensing feedback.","evidence":"In vitro phosphorylation, domain interaction, PI4P/transfer assays, sphingomyelin-depletion cell experiments; PP2Cepsilon reactivation by yeast two-hybrid, Co-IP and knockdown; PH domain PI4P specificity","pmids":["17442665","18165232","17314061"],"confidence":"High","gaps":["Kinase priming the SRM not yet identified","Structural basis of SRM–PH competition unresolved"]},{"year":2008,"claim":"Provided the structural mechanism for stereospecific ceramide recognition and chain-length cutoff, revealing a gated hydrophobic cavity.","evidence":"X-ray structures of apo and ceramide-bound START domain across multiple acyl chains","pmids":["18184806"],"confidence":"High","gaps":["Dynamics of the proposed alpha-3/Omega1 gate not directly observed","Membrane-engagement step not captured"]},{"year":2008,"claim":"Identified a stress-induced oligomeric off-state, showing UVB triggers a CERT homotrimer with reduced ceramide binding via the middle region.","evidence":"Western blot, mass spectrometry, ceramide binding assay, knockdown and HPA-12 in keratinocytes","pmids":["18411267"],"confidence":"Medium","gaps":["Single lab","Physiological trigger beyond UVB and structural basis of the trimer not defined"]},{"year":2009,"claim":"Captured the gating conformational change underlying ceramide loading/unloading by structurally trapping inhibitor-bound START with Trp473 repositioned.","evidence":"X-ray crystallography of HPA-bound START plus SPR on Trp473 membrane interaction","pmids":["20036255"],"confidence":"High","gaps":["Membrane-coupled release step inferred, not directly visualized","Kinetics of gating unresolved"]},{"year":2011,"claim":"Revealed that pathogens hijack CERT, with Chlamydia IncD directly binding the PH domain to recruit CERT to inclusion membrane contact sites for development.","evidence":"Co-IP, ectopic expression, knockdown, colocalization and bacterial development assays, replicated in two labs","pmids":["21731489","21909260"],"confidence":"High","gaps":["Did not quantify ceramide flux redirected to the inclusion","Whether IncD competes with native PI4P targeting unknown"]},{"year":2012,"claim":"Defined the PH-domain structural determinant of Golgi targeting—a basic groove adjacent to the PI4P site required for membrane recognition.","evidence":"Solution NMR structure, chemical-shift binding assays, cell-based mutant localization","pmids":["22869376"],"confidence":"High","gaps":["Interplay between basic groove and SRM autoinhibition not addressed here"]},{"year":2014,"claim":"Identified an activating phosphorylation arm (S315) that enhances VAP binding and transport, showing CERT is regulated by both off- and on-switches.","evidence":"Semi-intact cell transport, Co-IP, phosphomimetic mutants, imaging under sphingolipid depletion","pmids":["24569996"],"confidence":"High","gaps":["Kinase responsible for S315 phosphorylation not identified","Spatial scope of activation not yet resolved"]},{"year":2016,"claim":"Demonstrated a direct apoptotic consequence of ceramide trafficking by rerouting CERT-delivered ceramide to mitochondria.","evidence":"Engineered mitoCERT, domain/FFAT mutants, HPA-12, ceramide-synthesis inhibition, mitochondrial ceramidase, death assays","pmids":["27888218"],"confidence":"High","gaps":["Whether endogenous CERT physiologically delivers ceramide to mitochondria not established","Engineered anchor may not reflect native targeting"]},{"year":2018,"claim":"Provided the structural mechanism of SRM autoinhibition, showing hyperphosphorylated SRM electrostatically competes with PI4P binding on the PH domain.","evidence":"Solution NMR, PI4P-binding assay, Golgi-targeting imaging of 10E variant","pmids":["29848549"],"confidence":"High","gaps":["Quantitative contribution to START autoinhibition not separated","Dynamics in full-length protein not resolved"]},{"year":2018,"claim":"Extended CERT's role to extracellular vesicle biology and lipotoxic/metabolic control, linking ceramide transfer to EV biogenesis and insulin signaling.","evidence":"STARD11 knockout with EV/ceramide/viability readouts; CERT knockdown/overexpression in muscle with insulin signaling and caspase inhibition","pmids":["30139741","29759974"],"confidence":"Medium","gaps":["Single labs","Direct lipid-transfer requirement for EV phenotype not dissected from indirect ceramide accumulation"]},{"year":2021,"claim":"Linked CERT1 directly to human disease, identifying de novo gain-of-function variants impairing SRM autoregulation as causes of intellectual disability.","evidence":"Exome sequencing plus biochemical SRM-phosphorylation and localization analysis, with a non-impairing variant as negative control","pmids":["33347465","34688657"],"confidence":"Medium","gaps":["Single lab functional studies","Mechanism linking sphingolipid dysregulation to neurodevelopmental phenotype not defined"]},{"year":2022,"claim":"Mapped additional regulatory elements of autoinhibition and showed the activating and inhibitory phospho-arms are uncoupled with distinct spatial outputs.","evidence":"Alanine scanning of a coiled-coil K/R cluster with functional assays; hyperosmotic-stress S315 phosphorylation with Co-IP and localization","pmids":["35955719","35409383"],"confidence":"Medium","gaps":["Single lab","Structural basis of coiled-coil contribution to trimer stability not fully resolved"]},{"year":2022,"claim":"Showed CERT acts at ER–MVB contact sites with VAP-A to generate ceramide for a select RNA-containing EV population, and that HSV-1 pUL21 directly activates CERT by promoting its dephosphorylation.","evidence":"VAP-A/CERT knockdown with EV RNA/lipid profiling and imaging; SPR, SAXS structure of pUL21–CERT, mutagenesis and sphingolipid profiling","pmids":["35421371","36243114"],"confidence":"Medium","gaps":["EV study from single lab","How pUL21 mimics or bypasses host phosphatase regulation not fully defined"]},{"year":2023,"claim":"Refined the Golgi PI4P source and uncovered a second lipid cargo, establishing the C10orf76–PI4KB distal-Golgi axis and AAG transfer for ether phospholipid synthesis.","evidence":"Genome-wide screen, super-resolution imaging, PI4KB/ACBD3/C10orf76 perturbation; in vitro AAG transfer with HPA-12, domain deletion and knockdown/rescue lipidomics","pmids":["37195633","38110110"],"confidence":"High","gaps":["AAG transfer study single lab","Relative in vivo flux of ceramide versus AAG not quantified"]},{"year":2023,"claim":"Identified a dimeric helical domain mediating homeostatic autoregulation, integrating disease variants with a druggable mechanism via in vivo rescue.","evidence":"Structural characterization, patient variant analysis across 31 patients, Drosophila model with pharmacological CERT inhibition rescue","pmids":["36976648"],"confidence":"High","gaps":["Atomic structure of the dimeric domain in full-length context not resolved","Translation of pharmacological rescue to mammalian disease models pending"]},{"year":2025,"claim":"Connected CERT-mediated ceramide transfer to phospholipase C/PIP2 signaling physiology in vivo, showing it regulates GPCR–PLC photoreceptor responses.","evidence":"Drosophila dcert loss-of-function, electrophysiology, lipidomics and genetic suppression (preprint)","pmids":[],"confidence":"Medium","gaps":["Preprint, not peer-reviewed","Whether mechanism is conserved in mammals not established"]},{"year":null,"claim":"How CERT's two non-canonical isoform activities (GPBP kinase signaling/myofibril assembly and APP/Aβ modulation) relate mechanistically to its lipid-transfer function remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["GPBP kinase activity and myofibril/GIP130 roles characterized only in single studies (idx 26, 27)","CERTL–APP/Aβ interaction mechanism not integrated with ceramide transfer (idx 28)","Membrane-assisted ceramide release mechanism remains computational (idx 25)"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,3,24]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,1,24]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[4,8]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[1,4,8,23]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,5,15]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[15,22]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,23]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,4]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[12]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[7,20,21]}],"complexes":[],"partners":["VAPA","VAPB","PP2CEPSILON","C10ORF76","PI4KB","INCD","PUL21","APP"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y5P4","full_name":"Ceramide transfer protein","aliases":["Collagen type IV alpha-3-binding protein","Goodpasture antigen-binding protein","GPBP","START domain-containing protein 11","StARD11","StAR-related lipid transfer protein 11"],"length_aa":624,"mass_kda":70.8,"function":"Shelters ceramides inside its steroidogenic acute regulatory lipid transfer (START) domain and mediates their intracellular trafficking in a non-vesicular manner from the endoplasmic reticulum to the Golgi apparatus for conversion to sphingomyelin (PubMed:14685229, PubMed:15596449, PubMed:17591919, PubMed:18184806, PubMed:20036255). Efficiently transfers ceramide molecules having long-chain fatty chains, but not those with very long acyl chains (PubMed:15596449, PubMed:18184806). Capable of transferring diacylglycerol, although with very low efficiency (PubMed:18184806)","subcellular_location":"Cytoplasm; Golgi apparatus; Endoplasmic reticulum","url":"https://www.uniprot.org/uniprotkb/Q9Y5P4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CERT1","classification":"Not Classified","n_dependent_lines":45,"n_total_lines":1208,"dependency_fraction":0.037251655629139076},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000113163","cell_line_id":"CID000404","localizations":[{"compartment":"golgi","grade":3},{"compartment":"cytoplasmic","grade":2},{"compartment":"nucleoplasm","grade":1}],"interactors":[{"gene":"RPL38","stoichiometry":10.0},{"gene":"SFN","stoichiometry":0.2},{"gene":"TAF15","stoichiometry":0.2},{"gene":"RPL14","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000404","total_profiled":1310},"omim":[{"mim_id":"616351","title":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SPEECH DELAY, AND DYSMORPHIC FACIES; NEDHSF","url":"https://www.omim.org/entry/616351"},{"mim_id":"604677","title":"CERAMIDE TRANSPORTER 1; CERT1","url":"https://www.omim.org/entry/604677"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Golgi apparatus","reliability":"Enhanced"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CERT1"},"hgnc":{"alias_symbol":["GPBP","STARD11","CERT"],"prev_symbol":["COL4A3BP"]},"alphafold":{"accession":"Q9Y5P4","domains":[{"cath_id":"2.30.29.30","chopping":"27-120","consensus_level":"high","plddt":87.9452,"start":27,"end":120},{"cath_id":"3.30.530.20","chopping":"410-618","consensus_level":"high","plddt":94.3198,"start":410,"end":618},{"cath_id":"1.20.5","chopping":"239-303","consensus_level":"medium","plddt":86.0063,"start":239,"end":303}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y5P4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5P4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y5P4-F1-predicted_aligned_error_v6.png","plddt_mean":77.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CERT1","jax_strain_url":"https://www.jax.org/strain/search?query=CERT1"},"sequence":{"accession":"Q9Y5P4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y5P4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y5P4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y5P4"}},"corpus_meta":[{"pmid":"16895911","id":"PMC_16895911","title":"Efficient trafficking of ceramide from the endoplasmic reticulum to the Golgi apparatus requires a VAMP-associated protein-interacting FFAT motif of CERT.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16895911","citation_count":251,"is_preprint":false},{"pmid":"21731489","id":"PMC_21731489","title":"The lipid transfer protein CERT interacts with the Chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites.","date":"2011","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/21731489","citation_count":240,"is_preprint":false},{"pmid":"21909260","id":"PMC_21909260","title":"Chlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular development.","date":"2011","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/21909260","citation_count":191,"is_preprint":false},{"pmid":"15596449","id":"PMC_15596449","title":"CERT mediates intermembrane transfer of various molecular species of ceramides.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15596449","citation_count":189,"is_preprint":false},{"pmid":"18184806","id":"PMC_18184806","title":"Structural basis for specific lipid recognition by CERT responsible for nonvesicular trafficking of ceramide.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18184806","citation_count":176,"is_preprint":false},{"pmid":"19416656","id":"PMC_19416656","title":"CERT-mediated trafficking of ceramide.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19416656","citation_count":137,"is_preprint":false},{"pmid":"35421371","id":"PMC_35421371","title":"VAP-A and its binding partner CERT drive biogenesis of RNA-containing extracellular vesicles at ER membrane contact sites.","date":"2022","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/35421371","citation_count":105,"is_preprint":false},{"pmid":"17314061","id":"PMC_17314061","title":"CERT and intracellular trafficking of ceramide.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17314061","citation_count":104,"is_preprint":false},{"pmid":"17442665","id":"PMC_17442665","title":"Interorganelle trafficking of ceramide is regulated by phosphorylation-dependent cooperativity between the PH and START domains of CERT.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17442665","citation_count":98,"is_preprint":false},{"pmid":"31254361","id":"PMC_31254361","title":"Structure, functions and regulation of CERT, a lipid-transfer protein for the delivery of ceramide at the ER-Golgi membrane contact sites.","date":"2019","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/31254361","citation_count":88,"is_preprint":false},{"pmid":"18165232","id":"PMC_18165232","title":"Protein phosphatase 2Cepsilon is an endoplasmic reticulum integral membrane protein that dephosphorylates the ceramide transport protein CERT to enhance its association with organelle membranes.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18165232","citation_count":79,"is_preprint":false},{"pmid":"24569996","id":"PMC_24569996","title":"Phosphoregulation of the ceramide transport protein CERT at serine 315 in the interaction with VAMP-associated protein (VAP) for inter-organelle trafficking of ceramide in mammalian cells.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24569996","citation_count":76,"is_preprint":false},{"pmid":"24595143","id":"PMC_24595143","title":"Expression of the effector protein IncD in Chlamydia trachomatis mediates recruitment of the lipid transfer protein CERT and the endoplasmic reticulum-resident protein VAPB to the inclusion membrane.","date":"2014","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/24595143","citation_count":75,"is_preprint":false},{"pmid":"18459163","id":"PMC_18459163","title":"Two sphingolipid transfer proteins, CERT and FAPP2: their roles in sphingolipid metabolism.","date":"2008","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/18459163","citation_count":65,"is_preprint":false},{"pmid":"27888218","id":"PMC_27888218","title":"Diverting CERT-mediated ceramide transport to mitochondria triggers Bax-dependent apoptosis.","date":"2016","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/27888218","citation_count":63,"is_preprint":false},{"pmid":"27934691","id":"PMC_27934691","title":"Dead Cert: Measuring Cell Death.","date":"2016","source":"Cold Spring Harbor protocols","url":"https://pubmed.ncbi.nlm.nih.gov/27934691","citation_count":62,"is_preprint":false},{"pmid":"20036255","id":"PMC_20036255","title":"Crystal structures of the CERT START domain with inhibitors provide insights into the mechanism of ceramide transfer.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20036255","citation_count":59,"is_preprint":false},{"pmid":"21953249","id":"PMC_21953249","title":"CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction.","date":"2011","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21953249","citation_count":53,"is_preprint":false},{"pmid":"29343537","id":"PMC_29343537","title":"A search for ceramide binding proteins using bifunctional lipid analogs yields CERT-related protein StarD7.","date":"2018","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/29343537","citation_count":48,"is_preprint":false},{"pmid":"23845852","id":"PMC_23845852","title":"Co-evolution of sphingomyelin and the ceramide transport protein CERT.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23845852","citation_count":45,"is_preprint":false},{"pmid":"22869376","id":"PMC_22869376","title":"Structural basis for the Golgi association by the pleckstrin homology domain of the ceramide trafficking protein (CERT).","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22869376","citation_count":45,"is_preprint":false},{"pmid":"30139741","id":"PMC_30139741","title":"StAR-related lipid transfer domain 11 (STARD11)-mediated ceramide transport mediates extracellular vesicle biogenesis.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30139741","citation_count":43,"is_preprint":false},{"pmid":"12919427","id":"PMC_12919427","title":"The RHCE allele ceRT: D epitope 6 expression does not require D-specific amino acids.","date":"2003","source":"Transfusion","url":"https://pubmed.ncbi.nlm.nih.gov/12919427","citation_count":41,"is_preprint":false},{"pmid":"19428735","id":"PMC_19428735","title":"Heterologous expression of the lipid transfer protein CERT increases therapeutic protein productivity of mammalian cells.","date":"2009","source":"Journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/19428735","citation_count":40,"is_preprint":false},{"pmid":"33597019","id":"PMC_33597019","title":"CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer's disease.","date":"2021","source":"Alzheimer's research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33597019","citation_count":38,"is_preprint":false},{"pmid":"18411267","id":"PMC_18411267","title":"Decreased ceramide transport protein (CERT) function alters sphingomyelin production following UVB irradiation.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18411267","citation_count":38,"is_preprint":false},{"pmid":"28544656","id":"PMC_28544656","title":"The cellular ceramide transport protein CERT promotes Chlamydia psittaci infection and controls bacterial sphingolipid uptake.","date":"2017","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28544656","citation_count":37,"is_preprint":false},{"pmid":"33047409","id":"PMC_33047409","title":"Liposomal FRET Assay Identifies Potent Drug-Like Inhibitors of the Ceramide Transport Protein (CERT).","date":"2020","source":"Chemistry (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/33047409","citation_count":35,"is_preprint":false},{"pmid":"18068681","id":"PMC_18068681","title":"Ceramide traffic in C6 glioma cells: evidence for CERT-dependent and independent transport from ER to the Golgi apparatus.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/18068681","citation_count":35,"is_preprint":false},{"pmid":"29759974","id":"PMC_29759974","title":"Ceramide Transporter CERT Is Involved in Muscle Insulin Signaling Defects Under Lipotoxic Conditions.","date":"2018","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/29759974","citation_count":34,"is_preprint":false},{"pmid":"36976648","id":"PMC_36976648","title":"CERT1 mutations perturb human development by disrupting sphingolipid homeostasis.","date":"2023","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/36976648","citation_count":26,"is_preprint":false},{"pmid":"34947980","id":"PMC_34947980","title":"Ceramide Transfer Protein (CERT): An Overlooked Molecular Player in Cancer.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34947980","citation_count":26,"is_preprint":false},{"pmid":"22605339","id":"PMC_22605339","title":"Limonoid compounds inhibit sphingomyelin biosynthesis by preventing CERT protein-dependent extraction of ceramides from the endoplasmic reticulum.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22605339","citation_count":26,"is_preprint":false},{"pmid":"29848549","id":"PMC_29848549","title":"Phosphoinositide binding by the PH domain in ceramide transfer protein (CERT) is inhibited by hyperphosphorylation of an adjacent serine-repeat motif.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29848549","citation_count":25,"is_preprint":false},{"pmid":"33347465","id":"PMC_33347465","title":"Intellectual disability-associated gain-of-function mutations in CERT1 that encodes the ceramide transport protein CERT.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/33347465","citation_count":22,"is_preprint":false},{"pmid":"36243114","id":"PMC_36243114","title":"Herpes simplex virus 1 protein pUL21 alters ceramide metabolism by activating the interorganelle transport protein CERT.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36243114","citation_count":21,"is_preprint":false},{"pmid":"23676904","id":"PMC_23676904","title":"Engineering the cellular protein secretory pathway for enhancement of recombinant tissue plasminogen activator expression in Chinese hamster ovary cells: effects of CERT and XBP1s genes.","date":"2013","source":"Journal of microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/23676904","citation_count":21,"is_preprint":false},{"pmid":"30314703","id":"PMC_30314703","title":"Both the N- and C- terminal regions of the Chlamydial inclusion protein D (IncD) are required for interaction with the pleckstrin homology domain of the ceramide transport protein CERT.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30314703","citation_count":20,"is_preprint":false},{"pmid":"23246342","id":"PMC_23246342","title":"Ceramide and its transport protein (CERT) contribute to deterioration of mitochondrial structure and function in aging oocytes.","date":"2012","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/23246342","citation_count":19,"is_preprint":false},{"pmid":"7517426","id":"PMC_7517426","title":"Definition of encephalitogenic and immunodominant epitopes of guinea pig myelin basic protein (Gp-BP) in Lewis rats tolerized neonatally with Gp-BP or Gp-BP peptides.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7517426","citation_count":19,"is_preprint":false},{"pmid":"25256104","id":"PMC_25256104","title":"Identification of novel CERT ligands as potential ceramide trafficking inhibitors.","date":"2014","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/25256104","citation_count":16,"is_preprint":false},{"pmid":"34688657","id":"PMC_34688657","title":"Intellectual-disability-associated mutations in the ceramide transport protein gene CERT1 lead to aberrant function and subcellular distribution.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34688657","citation_count":15,"is_preprint":false},{"pmid":"22226883","id":"PMC_22226883","title":"Integration of non-vesicular and vesicular transport processes at the Golgi complex by the PKD-CERT network.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22226883","citation_count":15,"is_preprint":false},{"pmid":"25889812","id":"PMC_25889812","title":"A computational model of PKD and CERT interactions at the trans-Golgi network of mammalian cells.","date":"2015","source":"BMC systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/25889812","citation_count":15,"is_preprint":false},{"pmid":"37195633","id":"PMC_37195633","title":"The C10orf76-PI4KB axis orchestrates CERT-mediated ceramide trafficking to the distal Golgi.","date":"2023","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/37195633","citation_count":14,"is_preprint":false},{"pmid":"20177069","id":"PMC_20177069","title":"Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20177069","citation_count":13,"is_preprint":false},{"pmid":"25716975","id":"PMC_25716975","title":"Development of a CERT START Domain-Ceramide HTRF Binding Assay and Application to Pharmacological Studies and Screening.","date":"2015","source":"Journal of biomolecular screening","url":"https://pubmed.ncbi.nlm.nih.gov/25716975","citation_count":10,"is_preprint":false},{"pmid":"21832087","id":"PMC_21832087","title":"Goodpasture antigen-binding protein (GPBP) directs myofibril formation: identification of intracellular downstream effector 130-kDa GPBP-interacting protein (GIP130).","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21832087","citation_count":9,"is_preprint":false},{"pmid":"27031925","id":"PMC_27031925","title":"Asymmetric Synthesis and Binding Study of New Long-Chain HPA-12 Analogues as Potent Ligands of the Ceramide Transfer Protein CERT.","date":"2016","source":"Chemistry (Weinheim an der Bergstrasse, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/27031925","citation_count":8,"is_preprint":false},{"pmid":"35216212","id":"PMC_35216212","title":"Natural Ligand-Mimetic and Nonmimetic Inhibitors of the Ceramide Transport Protein CERT.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35216212","citation_count":6,"is_preprint":false},{"pmid":"28237558","id":"PMC_28237558","title":"Iminosugar-based ceramide mimicry for the design of new CERT START domain ligands.","date":"2017","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28237558","citation_count":6,"is_preprint":false},{"pmid":"31757669","id":"PMC_31757669","title":"N,O-Dialkyl deoxynojirimycin derivatives as CERT START domain ligands.","date":"2019","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/31757669","citation_count":6,"is_preprint":false},{"pmid":"35955719","id":"PMC_35955719","title":"Involvement of a Cluster of Basic Amino Acids in Phosphorylation-Dependent Functional Repression of the Ceramide Transport Protein CERT.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35955719","citation_count":6,"is_preprint":false},{"pmid":"35409383","id":"PMC_35409383","title":"Hyperosmotic Stress Induces Phosphorylation of CERT and Enhances Its Tethering throughout the Endoplasmic Reticulum.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35409383","citation_count":5,"is_preprint":false},{"pmid":"38903016","id":"PMC_38903016","title":"A Membrane-Assisted Mechanism for the Release of Ceramide from the CERT START Domain.","date":"2024","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/38903016","citation_count":4,"is_preprint":false},{"pmid":"39450584","id":"PMC_39450584","title":"Live-Cell Identification of Inhibitors of the Lipid Transfer Protein CERT Using Nanoluciferase Bioluminescence Resonance Energy Transfer (NanoBRET).","date":"2024","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/39450584","citation_count":3,"is_preprint":false},{"pmid":"33330630","id":"PMC_33330630","title":"Identification of the Interactions Interference Between the PH and START Domain of CERT by Limonoid and HPA Inhibitors.","date":"2020","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/33330630","citation_count":2,"is_preprint":false},{"pmid":"39684889","id":"PMC_39684889","title":"GPBP or CERT: The Roles in Autoimmunity, Cancer or Neurodegenerative Disease-A Systematic Review.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39684889","citation_count":1,"is_preprint":false},{"pmid":"9817524","id":"PMC_9817524","title":"The effects of the morphological response of Enterobacteriaceae to cephalosporins on PAE and CERT.","date":"1998","source":"Scandinavian journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/9817524","citation_count":1,"is_preprint":false},{"pmid":"40414946","id":"PMC_40414946","title":"Recruitment of the cellular lipid transport protein CERT to C. psittaci inclusions regulates the timing of bacterial egress.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40414946","citation_count":1,"is_preprint":false},{"pmid":"38110110","id":"PMC_38110110","title":"The ceramide transport protein CERT is involved in alkylacylglycerol transfer from the ER to the Golgi for the biosynthesis of ether phospholipid.","date":"2023","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/38110110","citation_count":0,"is_preprint":false},{"pmid":"41344499","id":"PMC_41344499","title":"Calcaratarin D exerts neuroprotective effects in Alzheimer's disease mouse model by inhibiting CERT-mediated NF-κB pathway.","date":"2025","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/41344499","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.18.670993","title":"Mild weight loss promotes plaque growth and synthesis of pro-atherogenic lipids in ApoE-deficient mice fed a high-fat, high-cholesterol diet","date":"2025-08-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.18.670993","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.05.668821","title":"Ceramide transfer protein regulates G-protein coupled phospholipase signalling in  <i>Drosophila</i>  photoreceptors","date":"2025-08-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.05.668821","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.23.25332034","title":"Real-Time HIIT Response in Patients with Coronary Artery Disease: A CERT-Based Report from the Heart-Brain Randomized Controlled Trial","date":"2025-07-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.23.25332034","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.16.654528","title":"ER-Localized Ceramide Accumulation Contributes to Replicative Senescence","date":"2025-05-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.16.654528","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.26.625409","title":"Recruitment of the cellular lipid transport protein CERT to  <i>C. psittaci</i>  inclusions regulates the timing of bacterial egress","date":"2024-11-26","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.26.625409","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.13.652513","title":"1-Deoxysphingolipids dysregulate membrane properties and cargo trafficking in the early secretory pathway","date":"2025-05-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.13.652513","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.03.616432","title":"VAPA mediates lipid exchange between  <i>Leishmania amazonensis</i>  and host macrophages","date":"2024-10-04","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.03.616432","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":34589,"output_tokens":7910,"usd":0.111209,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17706,"output_tokens":5497,"usd":0.112977,"stage2_stop_reason":"end_turn"},"total_usd":0.224186,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"CERT catalyzes intermembrane transfer of ceramide via its START domain, with strict stereo-specificity for the natural D-erythro isomer and an acyl-chain length limit (efficient for C14–C20 but not longer chains); it does not transfer sphingosine or sphingomyelin; (1R,3R)-HPA-12 was identified as an antagonist of the CERT START domain in vitro.\",\n      \"method\": \"Cell-free lipid transfer assay, lipid binding assay, radiolabeled ceramide analogs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with multiple lipid species, stereospecificity demonstrated, replicated across multiple conditions in one rigorous study\",\n      \"pmids\": [\"15596449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CERT requires both its PH domain (for Golgi targeting via PI4P) and its FFAT motif (for interaction with ER-resident VAP-A and VAP-B) for efficient ER-to-Golgi ceramide transport in cells; VAP-A and VAP-B co-immunoprecipitate with CERT and this interaction is abolished by FFAT motif mutations; neither FFAT nor PH domain mutations affect ceramide transfer activity in cell-free assays, indicating these domains spatially restrict the random transfer activity of the START domain.\",\n      \"method\": \"Co-immunoprecipitation, FFAT motif mutagenesis, semi-intact cell ceramide transport assay, cell-free lipid transfer assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (Co-IP, mutagenesis, cell-free and cell-based transport assays), single rigorous study with comprehensive controls\",\n      \"pmids\": [\"16895911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CERT activity is down-regulated by multiple phosphorylations at a serine-repeat motif (SRM), a substrate for casein kinase I; phosphorylation induces an autoinhibitory intramolecular interaction between the PH and START domains, inactivating both PI4P binding and ceramide transfer activities; loss of sphingomyelin and cholesterol causes dephosphorylation of CERT to activate it.\",\n      \"method\": \"In vitro phosphorylation assays, domain interaction assays, PI4P-binding assay, ceramide transfer assay, cell-based sphingomyelin depletion experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal biochemical assays plus cellular readouts in one study, with defined mechanistic outcome\",\n      \"pmids\": [\"17442665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structures of the CERT START domain in apo-form and in complex with ceramides of different acyl chain lengths reveal that one ceramide molecule is buried in a long amphiphilic cavity; hydrogen-bond networks at the far end of the cavity mediate stereo-specific ceramide recognition; cavity size dictates the acyl-chain length limit; the alpha-3 helix and Omega1 loop are proposed to act as a gate for ceramide entry.\",\n      \"method\": \"X-ray crystallography (crystal structures of apo and ceramide-bound START domain)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structures with functional validation of chain-length specificity, replicated across multiple ceramide species\",\n      \"pmids\": [\"18184806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CERT is preferentially distributed to the Golgi region in cells; its PH domain specifically recognizes phosphatidylinositol 4-monophosphate (PI4P) at the Golgi for targeting; membrane contact sites between ER and Golgi are proposed as sites of efficient ceramide transfer.\",\n      \"method\": \"Subcellular fractionation, domain binding studies, fluorescence localization\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — localization and domain-binding data from review consolidating prior experimental work, but this paper is a review summarizing established findings\",\n      \"pmids\": [\"17314061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PP2Cepsilon, an ER-resident transmembrane phosphatase, dephosphorylates CERT in a VAPA-dependent manner; PP2Cepsilon expression causes redistribution of CERT from cytoplasm to Golgi and enhances CERT-VAPA association; PP2Cepsilon knockdown attenuates CERT-VAPA interaction and sphingomyelin synthesis, identifying CERT as a physiological substrate of PP2Cepsilon.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, siRNA knockdown, subcellular localization by immunofluorescence, sphingomyelin synthesis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal interaction mapping, gain- and loss-of-function with two orthogonal readouts (CERT phosphorylation state and SM synthesis)\",\n      \"pmids\": [\"18165232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structures of the CERT START domain bound to HPA inhibitors reveal that the Omega1 loop adopts a different conformation compared to ceramide-bound structures, with Trp473 moving inside the cavity; surface plasmon resonance confirmed that Trp473 is important for membrane interaction, suggesting a gating mechanism for ceramide loading/unloading.\",\n      \"method\": \"X-ray crystallography, surface plasmon resonance\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures plus SPR validation of key residue, single lab but two orthogonal methods\",\n      \"pmids\": [\"20036255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Chlamydia trachomatis effector protein IncD directly binds the PH domain of CERT and recruits CERT to the inclusion membrane; this redirects ceramide trafficking toward the inclusion; CERT and VAP-A/B co-localize at ER-inclusion membrane contact sites; depletion of CERT or VAP proteins impairs bacterial development.\",\n      \"method\": \"Co-immunoprecipitation, ectopic expression, siRNA knockdown, immunofluorescence co-localization, bacterial development assay\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding demonstrated, loss-of-function phenotype, replicated across two independent laboratories (PMID 21731489 and 21909260)\",\n      \"pmids\": [\"21731489\", \"21909260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The CERT PH domain structure determined by solution NMR reveals a characteristic basic groove near the canonical PI4P recognition site; this basic groove coordinates efficient PI4P recognition and Golgi targeting; mutations of basic groove residues cause Golgi mislocalization in living cells.\",\n      \"method\": \"Solution NMR structure determination, NMR chemical shift perturbation binding assay, cell-based localization with mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with functional mutagenesis and cellular validation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"22869376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Phosphorylation of CERT at serine 315, adjacent to the FFAT motif, markedly enhances CERT-VAP interaction and ER-to-Golgi ceramide transport activity; the phosphomimetic S315E mutant shows higher ceramide transport activity in a semi-intact cell system; S315 phosphorylation increases under sphingolipid depletion conditions and acts additively with SRM dephosphorylation to activate CERT.\",\n      \"method\": \"Semi-intact cell ceramide transport assay, co-immunoprecipitation, CERT mutant analysis, immunofluorescence, biochemical phosphorylation analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical reconstitution in semi-intact cells, multiple mutant constructs, and cellular imaging, all in one study\",\n      \"pmids\": [\"24569996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Both the N- and C-terminal cytoplasmic regions of Chlamydia IncD are required for binding to the CERT PH domain; the IncD transmembrane region forms SDS-resistant homodimers and higher-order oligomers, which may facilitate high-affinity CERT binding.\",\n      \"method\": \"Co-transfection and co-immunoprecipitation, native gel electrophoresis, phylogenetic analysis\",\n      \"journal\": \"Infection and immunity / Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — direct binding defined by mutagenesis and co-IP, single lab with two orthogonal methods (Co-IP and native gel)\",\n      \"pmids\": [\"24595143\", \"30314703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Hyperphosphorylation-mimetic SRM substitutions (10E variant) cause an intramolecular interaction between the SRM and positively charged regions of the PH domain, directly competing with PI4P binding; this reduces PI4P-embedded membrane binding in cell-free assays and Golgi targeting in living cells.\",\n      \"method\": \"Solution NMR, PI4P-binding assay, fluorescence Golgi targeting assay in cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — NMR plus cell-free binding assay plus cellular imaging, single lab with three orthogonal methods\",\n      \"pmids\": [\"29848549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Targeting ceramide transport from ER to mitochondria using a mitoCERT construct (CERT with an outer mitochondrial membrane anchor) induces Bax-dependent apoptosis; apoptosis requires the ceramide transfer domain, VAP interaction via the ER, de novo ceramide synthesis, and is abolished by a bacterial ceramidase targeted to mitochondria — demonstrating that ER ceramide translocation to mitochondria directly commits cells to apoptosis.\",\n      \"method\": \"Engineered mitoCERT construct, domain deletion and FFAT mutants, CERT inhibitor HPA-12, de novo ceramide synthesis inhibition, mitochondria-targeted ceramidase, cell death assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal loss-of-function approaches (domain deletions, chemical inhibitors, enzymatic degradation) all converging on the same mechanistic conclusion in one rigorous study\",\n      \"pmids\": [\"27888218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"UVB irradiation induces formation of a stable CERT homotrimer complex in keratinocytes and other cell lines; the homotrimer formation requires the middle region domain of CERT (not the PH or START domains); CERT in the homotrimer has decreased ceramide binding activity; homotrimer formation correlates with decreased sphingomyelin synthesis and increased apoptosis.\",\n      \"method\": \"Western immunoblot, mass spectrometry, ceramide binding assay, siRNA knockdown, CERT inhibitor HPA-12\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (MS, WB, binding assay), domain mapping, but single lab\",\n      \"pmids\": [\"18411267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CERT function is down-regulated by multisite SRM phosphorylation primed by protein kinase D (activated by diacylglycerol produced during ceramide-to-sphingomyelin conversion), creating a feedback mechanism; S315 phosphorylation enhances CERT-VAP binding; the PI4P pool at trans-Golgi (regulated by PI4-kinases and OSBP) controls CERT-dependent ceramide transport.\",\n      \"method\": \"Biochemical phosphorylation analysis, cell-based assays, lipid measurement (review of experimental findings)\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — review paper consolidating experimental findings from multiple studies; PKD-primed SRM phosphorylation established in prior experimental work cited within\",\n      \"pmids\": [\"31254361\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CERT (STARD11) mediates palmitate-stimulated extracellular vesicle/exosome biogenesis in liver cells; STARD11-deficient cells release fewer extracellular vesicles, exhibit intracellular ceramide accumulation, and show reduced cellular viability; STARD11 co-localizes with ER and multivesicular bodies.\",\n      \"method\": \"STARD11 knockout cell lines, extracellular vesicle quantification, ceramide measurement, immunofluorescence co-localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout with multiple readouts (EV number, ceramide levels, cell viability), single lab\",\n      \"pmids\": [\"30139741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"De novo missense variants in CERT1 causing intellectual disability include gain-of-function mutations (e.g., S135P) that impair SRM hyperphosphorylation and thus prevent down-regulation of CERT activity; these mutations cause abnormal CERT activation and punctate subcellular redistribution.\",\n      \"method\": \"Whole exome sequencing, biochemical analysis of SRM phosphorylation, subcellular localization imaging\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical validation of phosphorylation defect plus cellular localization, single lab\",\n      \"pmids\": [\"33347465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ID-associated CERT1 mutations S132L and G243R impair SRM hyperphosphorylation, rendering the proteins excessively active and causing punctate subcellular redistribution; a frameshift variant (dupAA) that does not impair SRM phosphorylation does not cause aberrant activity or localization, serving as a disease-matched negative control.\",\n      \"method\": \"Biochemical phosphorylation analysis, subcellular localization imaging, patient variant characterization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical and cellular analyses with negative control variant, single lab\",\n      \"pmids\": [\"34688657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A previously uncharacterized cluster of lysine/arginine residues on the outer surface of a coiled-coil region of CERT is involved in SRM phosphorylation-dependent repression of CERT function; alanine substitutions in this cluster release repression of SM synthesis, PI4P-binding, VAP binding, ceramide transfer, and Golgi localization, and partially destabilize the CERT trimer.\",\n      \"method\": \"Site-directed mutagenesis, SM synthesis assay, PI4P-binding assay, VAP co-IP, ceramide transfer assay, subcellular localization\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays with alanine-scanning mutagenesis, single lab\",\n      \"pmids\": [\"35955719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Hyperosmotic stress induces S315 phosphorylation of CERT without altering SRM phosphorylation; under these conditions, CERT-VAP-A binding is enhanced throughout the ER (not only at ER-Golgi MCS), demonstrating that S315 phosphorylation and SRM dephosphorylation can be uncoupled and that they have distinct spatial consequences.\",\n      \"method\": \"Biochemical phosphorylation analysis, co-immunoprecipitation, immunofluorescence subcellular localization\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP and localization under defined stress conditions, single lab with two orthogonal methods\",\n      \"pmids\": [\"35409383\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"HSV-1 pUL21, a viral phosphatase adaptor, directly interacts with CERT with submicromolar affinity; pUL21 promotes dephosphorylation of CERT, activating it and accelerating ceramide-to-sphingomyelin conversion; solution structure of the pUL21 C-terminal domain in complex with CERT PH and START domains was determined by SAXS; a single conserved pUL21 surface residue disrupts CERT binding in vitro and in cells.\",\n      \"method\": \"Click chemistry sphingolipid profiling, surface plasmon resonance, small-angle X-ray scattering (SAXS), site-directed mutagenesis, co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — solution structure, affinity measurement, mutagenesis, and functional lipid profiling in one rigorous study\",\n      \"pmids\": [\"36243114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Several CERT1 intellectual disability variants fall in a previously uncharacterized dimeric helical domain that enables CERT homeostatic autoregulation/inactivation; disruption of this domain by de novo missense variants causes unchecked sphingolipid production; pharmacological CERT inhibition corrects morphological and motor abnormalities in a Drosophila model.\",\n      \"method\": \"Structural characterization of dimeric helical domain, patient variant analysis, Drosophila model with pharmacological rescue\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — structural domain characterization, multiple variants, and in vivo pharmacological rescue, replicated across 31 patients\",\n      \"pmids\": [\"36976648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"VAP-A and its binding partner CERT localize to multivesicular bodies (MVBs); knockdown of CERT or VAP-A reduces RNA content of small extracellular vesicles and ceramide in EVs; ceramide generated via the VAP-A/CERT axis at ER-MVB membrane contact sites drives biogenesis of a select RNA-containing EV population.\",\n      \"method\": \"siRNA knockdown, EV isolation and RNA/lipid profiling, live imaging, colocalization experiments\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockdown with multiple readouts (EV RNA, ceramide, MVB morphology), single lab\",\n      \"pmids\": [\"35421371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CERT preferentially utilizes PI4P generated by PI4KB recruited to the Golgi by C10orf76 (rather than ACBD3) for ceramide transport; super-resolution microscopy shows C10orf76 localizes predominantly at distal Golgi where sphingomyelin synthesis primarily occurs, while ACBD3 is at more proximal regions — establishing a C10orf76-PI4KB axis that orchestrates CERT-mediated ceramide delivery to distal Golgi.\",\n      \"method\": \"Genome-wide screening, PI4P measurement, super-resolution microscopy, knockdown/knockout of PI4KB, ACBD3, C10orf76\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide screen followed by super-resolution imaging and functional knockdown, single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"37195633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CERT mediates intermembrane transfer of alkylacylglycerol (AAG) in vitro; CERT inhibition (HPA-12) or START domain deletion abolishes AAG transfer; CERT suppression in HEK293 cells increases plasmanyl-PC levels (an AAG metabolite), and CERT re-introduction reduces these levels — identifying CERT as a transporter of AAG from ER to Golgi for ether phospholipid biosynthesis.\",\n      \"method\": \"In vitro lipid transfer assay, HPA-12 inhibition, domain deletion, CERT knockdown/rescue, cellular lipid measurement\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro transfer assay plus cellular gain/loss-of-function, single lab\",\n      \"pmids\": [\"38110110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Molecular dynamics simulations propose a membrane-assisted mechanism for ceramide release from the CERT START domain, in which membrane contact acts as allosteric effector and a single phosphatidylcholine lipid intercalates into the START cavity to facilitate ceramide egress; free energy calculations and experimental lipidomics confirmed CERT forms stable complexes with phosphatidylcholine in addition to ceramide.\",\n      \"method\": \"Molecular dynamics simulations, free energy calculations, experimental lipidomics\",\n      \"journal\": \"The journal of physical chemistry B\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — primarily computational with limited experimental lipidomics validation; mechanism not directly demonstrated by biochemical reconstitution\",\n      \"pmids\": [\"38903016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Human biliverdin reductase (hBVR) binds to GPBP (CERT1 long isoform) and down-regulates its TNF-alpha-stimulated kinase activity in HEK293A cells; hBVR siRNA knockdown modulates TNF-alpha/NF-κB-stimulated GPBP expression; the interacting domain was mapped to the C-terminal CX10C motif of hBVR.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, kinase activity assay, peptide mapping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP with domain mapping and functional kinase assay, single lab\",\n      \"pmids\": [\"20177069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GPBP-1 (the long isoform of CERT1) accumulates in cytoplasm of differentiating myoblasts prior to myosin synthesis; GPBP-1-deficient myoblasts show defective myofibril formation; GPBP-1 targets GIP130 (a 130-kDa interacting protein), which binds myosin and promotes its myofibrillar assembly.\",\n      \"method\": \"Loss-of-function (deficiency), overexpression, co-immunoprecipitation (GPBP-GIP130), myofibril formation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP identifying binding partner plus cellular loss-of-function phenotype, single lab\",\n      \"pmids\": [\"21832087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CERTL (long isoform) binds to amyloid precursor protein (APP) as shown by co-immunoprecipitation; recombinant CERTL modifies Aβ aggregation and reduces Aβ neurotoxicity in neuroblastoma cells; CERTL overexpression in 5xFAD mouse brains reduces ceramide d18:1/16:0 levels, increases sphingomyelin, decreases Aβ formation, and modulates microglia toward a less pro-inflammatory phenotype.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, AAV-mediated overexpression in mice, mass spectrometry lipidomics, immunohistochemistry, behavior tests\",\n      \"journal\": \"Alzheimer's research & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus in vivo mouse overexpression with lipidomic and immunological readouts, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"33597019\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CERT protein expression is reduced in insulin-resistance models via caspase-dependent cleavage; inhibiting CERT activity potentiates lipotoxicity-induced insulin signaling defects; CERT overexpression in vitro and in vivo decreases muscle ceramide content and improves insulin signaling; inhibition of caspase activity prevents ceramide-induced insulin signaling defects.\",\n      \"method\": \"CERT knockdown/overexpression in muscle cells, in vivo overexpression, insulin signaling assays, ceramide measurement, caspase inhibition\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with defined biochemical readouts (ceramide levels, insulin signaling), single lab with multiple approaches\",\n      \"pmids\": [\"29759974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"C. psittaci recruits CERT to its inclusion; CERT knockout (CRISPR/Cas9) impairs C. psittaci infection, affecting inclusion growth and infectious progeny formation; CERT-independent sphingolipid uptake pathways exist in CERT-KO cells, and HPA-12 sensitive factors beyond CERT are involved in sphingolipid trafficking to C. psittaci.\",\n      \"method\": \"CRISPR/Cas9 CERT knockout, CERT chemical inhibition (HPA-12), fluorescent sphingolipid uptake assay, bacterial development quantification\",\n      \"journal\": \"Cellular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with multiple functional readouts, single lab\",\n      \"pmids\": [\"28544656\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In Drosophila, loss of dcert leads to elevated short-chain ceramide and reduced phosphatidylethanolamine ceramide; dcert mutants show reduced photoreceptor electrical responses to light and impaired PIP2 resynthesis following PLC activation; reducing ceramide synthesis at the ER suppresses the dcert light response phenotype — establishing that CERT-mediated ceramide transfer from ER to Golgi regulates G-protein coupled phospholipase C signaling in vivo.\",\n      \"method\": \"Loss-of-function alleles, electrophysiology (ERG), lipidomics, genetic suppressor (ceramide synthesis reduction), rescue with wild-type gene\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with physiological and lipidomic readouts in Drosophila, preprint not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"CERT1/CERT is a cytosolic ceramide transfer protein that extracts ceramide from the ER via its START domain (which binds one ceramide molecule stereospecifically in a hydrophobic cavity) and delivers it to the trans-Golgi for sphingomyelin synthesis; ER targeting is mediated by a FFAT motif that binds VAP-A/B, Golgi targeting by a PH domain that recognizes PI4P generated specifically by the C10orf76-PI4KB axis at distal Golgi; CERT activity is regulated by a phosphorylation-feedback loop in which PKD-primed multisite SRM phosphorylation causes autoinhibitory PH-START domain interaction (releasing Golgi binding) while phosphorylation at S315 enhances VAP binding and activates CERT, and PP2Cepsilon dephosphorylates CERT at the ER to reactivate it; de novo ID-associated gain-of-function mutations impair SRM phosphorylation-dependent autoregulation, including via a newly identified dimeric helical domain, causing uncontrolled sphingolipid production; CERT also transfers alkylacylglycerol for ether phospholipid biosynthesis, participates in ceramide delivery to multivesicular bodies for RNA-containing EV biogenesis, and is co-opted by intracellular pathogens (Chlamydia, HSV-1) via direct protein-protein interactions with CERT's PH or START domains.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CERT1 (CERT/STARD11/GPBP) is a cytosolic lipid-transfer protein that drives non-vesicular delivery of ceramide from the endoplasmic reticulum to the Golgi for sphingomyelin synthesis [#0, #1]. Its START domain extracts and stereospecifically binds a single D-erythro ceramide within an amphiphilic cavity whose size sets an acyl-chain-length limit, with the Omega1 loop and Trp473 acting as a gate for lipid loading and release [#0, #3, #6]. Spatial coupling of this intrinsically random transfer activity is achieved by two targeting modules: a FFAT motif that binds the ER-resident proteins VAP-A/VAP-B and a PH domain that recognizes Golgi PI4P through a basic groove, positioning CERT at ER–Golgi membrane contact sites [#1, #8]; CERT preferentially consumes the distal-Golgi PI4P pool generated by a C10orf76–PI4KB axis where sphingomyelin synthesis occurs [#23]. CERT activity is governed by a phosphorylation feedback loop: multisite serine-repeat-motif (SRM) phosphorylation, primed by diacylglycerol-activated PKD, drives an autoinhibitory intramolecular SRM–PH interaction that competes with PI4P binding and silences transfer, while the ER phosphatase PP2Cepsilon reactivates CERT in a VAP-dependent manner, and phosphorylation at S315 adjacent to the FFAT motif independently enhances VAP binding to activate the protein [#2, #5, #9, #11, #19]. Beyond canonical sphingomyelin production, CERT supplies ceramide for multivesicular-body/extracellular-vesicle biogenesis at ER–MVB contact sites and transfers alkylacylglycerol for ether phospholipid synthesis [#22, #24], and targeted ER-to-mitochondria ceramide transport commits cells to Bax-dependent apoptosis [#12]. De novo gain-of-function CERT1 missense variants causing intellectual disability cluster in regulatory regions—including the SRM and a dimeric helical domain—where they impair SRM hyperphosphorylation-dependent autoinhibition, producing unchecked sphingolipid production that is corrected by pharmacological CERT inhibition in a Drosophila model [#16, #17, #21]. CERT is also co-opted by intracellular pathogens, with Chlamydia IncD and HSV-1 pUL21 binding CERT domains directly to redirect or activate ceramide trafficking [#7, #20].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established that CERT is a bona fide ceramide carrier, defining its core biochemical activity and substrate selectivity.\",\n      \"evidence\": \"Cell-free lipid transfer and binding assays with radiolabeled ceramide analogs\",\n      \"pmids\": [\"15596449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve how the random transfer activity is spatially organized in cells\", \"Structural basis of stereospecificity not yet defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Resolved how CERT's intrinsically directionless transfer is harnessed for vectorial ER-to-Golgi transport, showing the FFAT (VAP) and PH (PI4P) modules spatially constrain the START domain.\",\n      \"evidence\": \"Co-IP with VAP-A/B, FFAT mutagenesis, semi-intact cell transport and cell-free transfer assays\",\n      \"pmids\": [\"16895911\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address how the two targeting events are coordinated dynamically\", \"Regulation of the cycle unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined the principal off-switch—SRM phosphorylation causing autoinhibitory PH–START interaction—and linked it to sphingolipid-sensing feedback.\",\n      \"evidence\": \"In vitro phosphorylation, domain interaction, PI4P/transfer assays, sphingomyelin-depletion cell experiments; PP2Cepsilon reactivation by yeast two-hybrid, Co-IP and knockdown; PH domain PI4P specificity\",\n      \"pmids\": [\"17442665\", \"18165232\", \"17314061\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase priming the SRM not yet identified\", \"Structural basis of SRM–PH competition unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Provided the structural mechanism for stereospecific ceramide recognition and chain-length cutoff, revealing a gated hydrophobic cavity.\",\n      \"evidence\": \"X-ray structures of apo and ceramide-bound START domain across multiple acyl chains\",\n      \"pmids\": [\"18184806\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamics of the proposed alpha-3/Omega1 gate not directly observed\", \"Membrane-engagement step not captured\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified a stress-induced oligomeric off-state, showing UVB triggers a CERT homotrimer with reduced ceramide binding via the middle region.\",\n      \"evidence\": \"Western blot, mass spectrometry, ceramide binding assay, knockdown and HPA-12 in keratinocytes\",\n      \"pmids\": [\"18411267\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Physiological trigger beyond UVB and structural basis of the trimer not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Captured the gating conformational change underlying ceramide loading/unloading by structurally trapping inhibitor-bound START with Trp473 repositioned.\",\n      \"evidence\": \"X-ray crystallography of HPA-bound START plus SPR on Trp473 membrane interaction\",\n      \"pmids\": [\"20036255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Membrane-coupled release step inferred, not directly visualized\", \"Kinetics of gating unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Revealed that pathogens hijack CERT, with Chlamydia IncD directly binding the PH domain to recruit CERT to inclusion membrane contact sites for development.\",\n      \"evidence\": \"Co-IP, ectopic expression, knockdown, colocalization and bacterial development assays, replicated in two labs\",\n      \"pmids\": [\"21731489\", \"21909260\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not quantify ceramide flux redirected to the inclusion\", \"Whether IncD competes with native PI4P targeting unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined the PH-domain structural determinant of Golgi targeting—a basic groove adjacent to the PI4P site required for membrane recognition.\",\n      \"evidence\": \"Solution NMR structure, chemical-shift binding assays, cell-based mutant localization\",\n      \"pmids\": [\"22869376\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between basic groove and SRM autoinhibition not addressed here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified an activating phosphorylation arm (S315) that enhances VAP binding and transport, showing CERT is regulated by both off- and on-switches.\",\n      \"evidence\": \"Semi-intact cell transport, Co-IP, phosphomimetic mutants, imaging under sphingolipid depletion\",\n      \"pmids\": [\"24569996\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for S315 phosphorylation not identified\", \"Spatial scope of activation not yet resolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated a direct apoptotic consequence of ceramide trafficking by rerouting CERT-delivered ceramide to mitochondria.\",\n      \"evidence\": \"Engineered mitoCERT, domain/FFAT mutants, HPA-12, ceramide-synthesis inhibition, mitochondrial ceramidase, death assays\",\n      \"pmids\": [\"27888218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endogenous CERT physiologically delivers ceramide to mitochondria not established\", \"Engineered anchor may not reflect native targeting\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Provided the structural mechanism of SRM autoinhibition, showing hyperphosphorylated SRM electrostatically competes with PI4P binding on the PH domain.\",\n      \"evidence\": \"Solution NMR, PI4P-binding assay, Golgi-targeting imaging of 10E variant\",\n      \"pmids\": [\"29848549\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution to START autoinhibition not separated\", \"Dynamics in full-length protein not resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended CERT's role to extracellular vesicle biology and lipotoxic/metabolic control, linking ceramide transfer to EV biogenesis and insulin signaling.\",\n      \"evidence\": \"STARD11 knockout with EV/ceramide/viability readouts; CERT knockdown/overexpression in muscle with insulin signaling and caspase inhibition\",\n      \"pmids\": [\"30139741\", \"29759974\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single labs\", \"Direct lipid-transfer requirement for EV phenotype not dissected from indirect ceramide accumulation\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linked CERT1 directly to human disease, identifying de novo gain-of-function variants impairing SRM autoregulation as causes of intellectual disability.\",\n      \"evidence\": \"Exome sequencing plus biochemical SRM-phosphorylation and localization analysis, with a non-impairing variant as negative control\",\n      \"pmids\": [\"33347465\", \"34688657\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab functional studies\", \"Mechanism linking sphingolipid dysregulation to neurodevelopmental phenotype not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mapped additional regulatory elements of autoinhibition and showed the activating and inhibitory phospho-arms are uncoupled with distinct spatial outputs.\",\n      \"evidence\": \"Alanine scanning of a coiled-coil K/R cluster with functional assays; hyperosmotic-stress S315 phosphorylation with Co-IP and localization\",\n      \"pmids\": [\"35955719\", \"35409383\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Structural basis of coiled-coil contribution to trimer stability not fully resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed CERT acts at ER–MVB contact sites with VAP-A to generate ceramide for a select RNA-containing EV population, and that HSV-1 pUL21 directly activates CERT by promoting its dephosphorylation.\",\n      \"evidence\": \"VAP-A/CERT knockdown with EV RNA/lipid profiling and imaging; SPR, SAXS structure of pUL21–CERT, mutagenesis and sphingolipid profiling\",\n      \"pmids\": [\"35421371\", \"36243114\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"EV study from single lab\", \"How pUL21 mimics or bypasses host phosphatase regulation not fully defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Refined the Golgi PI4P source and uncovered a second lipid cargo, establishing the C10orf76–PI4KB distal-Golgi axis and AAG transfer for ether phospholipid synthesis.\",\n      \"evidence\": \"Genome-wide screen, super-resolution imaging, PI4KB/ACBD3/C10orf76 perturbation; in vitro AAG transfer with HPA-12, domain deletion and knockdown/rescue lipidomics\",\n      \"pmids\": [\"37195633\", \"38110110\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"AAG transfer study single lab\", \"Relative in vivo flux of ceramide versus AAG not quantified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified a dimeric helical domain mediating homeostatic autoregulation, integrating disease variants with a druggable mechanism via in vivo rescue.\",\n      \"evidence\": \"Structural characterization, patient variant analysis across 31 patients, Drosophila model with pharmacological CERT inhibition rescue\",\n      \"pmids\": [\"36976648\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic structure of the dimeric domain in full-length context not resolved\", \"Translation of pharmacological rescue to mammalian disease models pending\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Connected CERT-mediated ceramide transfer to phospholipase C/PIP2 signaling physiology in vivo, showing it regulates GPCR–PLC photoreceptor responses.\",\n      \"evidence\": \"Drosophila dcert loss-of-function, electrophysiology, lipidomics and genetic suppression (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not peer-reviewed\", \"Whether mechanism is conserved in mammals not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How CERT's two non-canonical isoform activities (GPBP kinase signaling/myofibril assembly and APP/Aβ modulation) relate mechanistically to its lipid-transfer function remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GPBP kinase activity and myofibril/GIP130 roles characterized only in single studies (idx 26, 27)\", \"CERTL–APP/Aβ interaction mechanism not integrated with ceramide transfer (idx 28)\", \"Membrane-assisted ceramide release mechanism remains computational (idx 25)\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 3, 24]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 1, 24]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [4, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [1, 4, 8, 23]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 5, 15]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [15, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 23]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 20, 21]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"VAPA\", \"VAPB\", \"PP2Cepsilon\", \"C10orf76\", \"PI4KB\", \"IncD\", \"pUL21\", \"APP\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"loss","faith_supported":7,"faith_total":7,"faith_pct":100.0}}